Ticker > Company >

Cian Healthcare share price

Cian Healthcare Ltd.

BSE: 542678 SECTOR: Pharmaceuticals & Drugs  17k   18   2

4.34
0 0
BSE: 20 Dec 04:01 PM

Price Summary

Today's High

₹ 4.35

Today's Low

₹ 4.34

52 Week High

₹ 26.5

52 Week Low

₹ 4.12

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

10.85 Cr.

Enterprise Value

51.13 Cr.

No. of Shares

2.5 Cr.

P/E

27.84

P/B

0.25

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  17.52

CASH

0.73 Cr.

DEBT

41.01 Cr.

Promoter Holding

27.1 %

EPS (TTM)

₹  0.16

Sales Growth

-13.04%

ROE

0.82 %

ROCE

5.54%

Profit Growth

-63.82 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Cian Healthcare Ltd.

celesta norwich jmsims gelios cardiac care trans I vac cianstar cinex blue care

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-13.04%
3 Year-6.72%
5 Year-1.21%

Profit Growth

1 Year-63.82%
3 Year6.04%
5 Year-9.87%

ROE%

1 Year0.82%
3 Year-0.42%
5 Year-0.17%

ROCE %

1 Year5.54%
3 Year4.84%
5 Year5.65%

Debt/Equity

0.9365

Price to Cash Flow

1.56

Interest Cover Ratio

1.0026

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 27.10 34.48
Jun 2024 27.10 99.87
Mar 2024 27.10 47.77
Sep 2023 49.62 18.83
Mar 2023 51.85 18.02
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of -310.2172 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 8.88267219927784.

 Limitations

  • The company has shown a poor profit growth of 6.04493687297503% for the Past 3 years.
  • The company has shown a poor revenue growth of -6.71998177964366% for the Past 3 years.
  • Company has a poor ROE of -0.42389170229646% over the past 3 years.
  • Company has a poor ROCE of 4.8372423646134% over the past 3 years
  • The company is trading at a high PE of 27.84.
  • Promoter pledging is high as 34.48%.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 57.05 72.38 64.1 67.56 58.75
Total Expenditure 49.34 62.99 59.07 58.5 51.18
Operating Profit 7.71 9.39 5.04 9.06 7.57
Other Income 0.79 0.33 0.47 0.54 1.06
Interest 5.9 6.4 5.25 4.79 4.93
Depreciation 2.45 2.45 2.57 3.64 3.68
Exceptional Items -0.07 -0.2 -0.07 0.03 0
Profit Before Tax 0.07 0.67 -2.38 1.2 0.01
Tax 0.15 0.34 -0.1 0.12 -0.38
Net Profit -0.07 0.33 -2.28 1.08 0.39
Adjusted EPS (Rs.) -0.03 0.14 -0.91 0.43 0.16

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 23.36 23.36 25 25 25
Total Reserves 36.19 36.51 35.35 36.43 36.82
Borrowings 24.49 18.37 19.99 12.9 15.29
Other N/C liabilities 2.95 3.34 2.58 8.32 9.63
Current liabilities 47.7 53.05 56.87 57.99 56.16
Total Liabilities 134.69 134.63 139.78 140.63 142.89
Assets
Net Block 20.78 18.73 32.82 29.42 25.88
Capital WIP 24.8 25.71 13 13.89 14.7
Intangible WIP 0 0 0 0 0
Investments 7.09 7.09 7.09 7.09 7.09
Loans & Advances 22.55 19.95 15.19 11.95 12.44
Other N/C Assets 7.92 5.48 2.9 10.05 18.02
Current Assets 51.55 57.67 68.79 68.24 64.76
Total Assets 134.69 134.63 139.78 140.63 142.89
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.07 0.33 -2.28 1.08 0.39
Adjustment 7.9 8.1 7.1 7.6 7.82
Changes in Assets & Liabilities -17.22 -2.96 0.69 -6.53 -1.26
Tax Paid 0 0 0 0 0
Operating Cash Flow -9.24 5.46 5.51 2.15 6.94
Investing Cash Flow -25.16 -1.2 -3.85 -1.08 -0.93
Financing Cash Flow 35.09 -5.07 -2.65 -1.17 -6.41
Net Cash Flow 0.69 -0.81 -0.99 -0.1 -0.4

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Sep 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 51.85 49.62 27.10 27.10 27.10
kavita suraj zanwar 9.60 9.06 1.21 1.21 1.21
pankaj shriniwas zanwar 16.80 16.80 13.76 13.76 13.76
shakuntala shriniwas zanw... 2.40 2.40 2.04 2.04 2.04
suraj shriniwas zanwar 23.04 21.36 10.09 10.09 10.09
PARTICULARS Mar 2023% Sep 2023% Mar 2024% Jun 2024% Sep 2024%
investors 48.15 50.38 72.90 72.90 72.90
dayal tours and travels i... - - 2.00 2.00 2.00
girija amit sharma 1.82 1.82 1.82 2.02 2.23
kaushal sunil tambe - - 1.50 1.50 1.10
prakashchandra rathi 20.00 15.90 15.42 - 15.42
ravi ashok kothari - - 2.52 2.52 1.32
sahi trading private limi... - 4.38 4.02 4.02 1.22
sonali dilip sanklecha - - 4.00 4.00 3.79
amitkumar ramanlal lodha - - - 1.04 -
archana mandhani 1.16 1.16 1.16 1.16 -
prakashchandra rathi . - - - 15.42 -
samar shahaji ransing - - - 1.05 -
shweta sachin bhansali - - 1.05 1.05 -
koushal govindprasad shar... 1.60 1.60 1.60 - -
indiacredit risk manageme... 2.55 - - - -

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Cian Healthcare informs about update on CoC 7 Dec, 12:44 PM Cian Healthcare informs about outcome of AGM 8 Oct, 4:36 PM Cian Healthcare informs about CoC meeting proceedings 12 Sep, 4:33 PM Cian Healthcare informs about change in corporate office address 23 Aug, 5:03 PM Cian Healthcare informs about published announcement 19 Aug, 5:15 PM Cian Healthcare informs about disclosure 21 Jun, 3:02 PM Cian Healthcare informs about receipt of adjudication order of penalties 19 Mar, 4:55 PM Cian Healthcare informs about disclosure 6 Dec, 5:06 PM Cian Healthcare enters into agreement with HLL Lifecare 6 Dec, 12:48 PM Cian Healthcare informs about disclosure 9 Nov, 2:23 PM Cian Healthcare informs about disclosure 4 Nov, 12:16 PM Cian Healthcare informs about disclosure 12 Oct, 3:12 PM Cian Healthcare informs about appointment of additional director 12 Oct, 3:04 PM Cian Healthcare inks merchant export agreement with Tamil Pharma 11 Oct, 5:13 PM Cian Healthcare informs about disclosure 11 Oct, 4:42 PM Cian Healthcare enters into agreement with CHI Pharmaceuticals, Nigeria 22 Aug, 12:59 PM Cian Healthcare gets nod to dispose off 100% stake in Dr. Smiths Biotech 10 Jun, 4:27 PM Cian Healthcare submits revised audited financial results 2 Jun, 4:01 PM Cian Healthcare informs about board meeting 24 May, 12:38 PM Cian Healthcare informs about outcome of board meeting 27 Sep, 3:18 PM Cian Healthcare informs about annual report 5 Sep, 5:08 PM Cian Healthcare informs about appointment of director 26 Aug, 12:57 PM Cian Healthcare informs about compliance certificate 22 Apr, 1:19 PM Cian Healthcare informs about compliance certificate 22 Apr, 1:01 PM Cian Healthcare informs about disclosure 27 Dec, 1:03 PM Cian Healthcare informs about board meeting 18 Dec, 11:34 AM Cian Healthcare informs about EGM proceedings 25 Nov, 4:47 PM Cian Healthcare informs about outcome of EGM meeting 24 Nov, 1:40 PM Cian Healthcare informs about newspaper publication 23 Nov, 1:41 PM Cian Healthcare informs outcome of about board meeting 22 Nov, 10:43 AM Cian Healthcare informs about EGM 1 Nov, 11:07 AM Cian Healthcare informs about revised notice of EGM 23 Oct, 10:21 AM Cian Healthcare informs about resignation of director 16 Oct, 3:22 PM Cian Healthcare informs about outcome of EGM 12 Oct, 12:52 PM Cian Healthcare informs about certificate 6 Oct, 9:55 AM Cian Healthcare informs about AGM 30 Sep, 4:50 PM Cian Healthcare informs about EGM notice 20 Sep, 11:32 AM Cian Healthcare informs about outcome of board meeting 18 Sep, 1:09 PM

Cian Healthcare Stock Price Analysis and Quick Research Report. Is Cian Healthcare an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Cian Healthcare and its performance over the period of time. Cian Healthcare stock price today is Rs 4.34.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Cian Healthcare cash from the operating activity was Rs 6.9413 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Cian Healthcare has a Debt to Equity ratio of 0.9365 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Cian Healthcare , the EPS growth was -63.8115 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Cian Healthcare has OPM of 12.8778581386205 % which is a bad sign for profitability.
     
  • ROE: Cian Healthcare have a poor ROE of 0.8188 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Cian Healthcare is Rs 4.34. One can use valuation calculators of ticker to know if Cian Healthcare share price is undervalued or overvalued.
Last Updated on:
Brief about Cian Healthcare
X